Filing Details
- Accession Number:
- 0001415889-22-008955
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-08-23 12:12:15
- Reporting Period:
- 2022-08-01
- Accepted Time:
- 2022-08-23 12:12:15
- Original Submission Date:
- 2022-08-02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1203346 | Doug G Iiekking | 3838 West Parkway Blvd Salt Lake City UT 84120 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-08-01 | 2,924 | $70.51 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The Form 4 filed 08/02/2022 disclosed an incorrect number of 1,086 shares sold. The actual number of shares sold is 2,924.
- The number of shares beneficially owned following the reported transaction has been adjusted to reflect the additional shares sold as noted in Footnote 1 above.